Skip to main content
. Author manuscript; available in PMC: 2019 Feb 20.
Published in final edited form as: AIDS. 2018 Feb 20;32(4):419–429. doi: 10.1097/QAD.0000000000001704

Figure 4. THC but not CBD decreased the percentage of CD16+, CD163+ and CD16+CD163+ cells within the monocyte population of IFNα-treated PBMCs.

Figure 4

PBMCs from HIV-MJ− donors (N=5) were pretreated with 0 (vehicle), 1, 5 and 10μM of THC or 1, 5 and 10μM of CBD for 0.5h and stimulated with IFNα (50U/ml) for 48h. *Statistically different from vehicle control (50 U/mL IFNα+vehicle) group (p<0.05, RM one-way ANOVA with a Dunnett’s multiple comparisons post-test). NS represents vehicle without IFNα addition. Graphs in A–C are mean +/− SEM.